In T2DM, periconceptional, noninsulin, second-line antidiabetes medications were not linked to major congenital malformations vs. insulin

Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0015. Online ahead of print.ABSTRACTCesta CE, Rotem R, Bateman BT, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med. 2024;184:144-152. 38079178.PMID:38560907 | DOI:10.7326/J24-0015
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Source Type: research